An FDA advisory committee will meet this week to review data from clinical trials of
the experimental diabetes drug dapagliflozin, which have revealed an unusually high number of users who developed bladder cancer or breast cancer.
An experimental diabetes drug could be used to end the agony of transplant rejection, British scientists said.
Not exact matches
Within the framework of research projects of the German Center for
Diabetes Research (DZD), scientists of the Research Unit Protein Science (PROT) and the Institute of
Experimental Genetics (IEG) at Helmholtz Zentrum München (HMGU) have now investigated how
drug treatment affects these signal carriers.
Cell transplantation as a treatment for
diabetes is still essentially
experimental, uses cells from cadavers, requires the use of powerful immunosuppressive
drugs, and has been available to only a very small number of patients.
An
experimental oral
drug has lowered blood sugar levels and inflammation in mice with Type 2
diabetes, suggesting that the medication could someday be added to the arsenal of
drugs used by millions of Americans with this disease, according to new research.
This
experimental treatment for type 1
diabetes combines the Encaptra ™
drug delivery system, which is a semi-permeable pouch, and PEC - 01 ™ cells, pancreatic precursor cells derived from human embryonic stem cells.
An
experimental drug making its way through clinical trials not only shows promise in helping obese patients lose weight, but it also may improve blood sugar in those who are obese and have type 2
diabetes.